首页> 外文期刊>Genetic testing and molecular biomarkers >Analysis of a Large-Scale Screening of Mitochondrial DNA m.1555A>G Mutation in 2417 Deaf-Mute Students in Northwest of China
【24h】

Analysis of a Large-Scale Screening of Mitochondrial DNA m.1555A>G Mutation in 2417 Deaf-Mute Students in Northwest of China

机译:西北地区2417名聋哑学生线粒体DNA m.1555A> G突变的大规模筛选分析

获取原文
获取原文并翻译 | 示例
           

摘要

The ancient Silk Road (also called "Northwest Silk Road") in Northwest China, starting from Xi'an, passes through Gansu, Xinjiang, Central Asia, West Asia, and the land passage connecting the Mediterranean countries. The aim of the present study was to determine the frequency of mitochondrial DNA12SrRNA m.l555A>G mutation in a total of 2417 cases of nonsyndromic deaf-mute patients representative of the general population of Shaanxi, Gansu, Qinghai, Ningxia, and Xinjiang along the Silk Road. Enzyme digestion and direct sequencing were applied to identify sequence variations. The carrier frequency of mitochondrial DNA12S rRNA m.l555A>G mutation was estimated to be 5.21% (126/2417) in the studied population. In detail, the carrier frequency of Uighur and Hui was 1.62% (3/185) and 3.29% (10/304), respectively, compared with 6.09% (113/1856) that of Han. There was a statistically significant difference between Uighur and Han (chi-square test, χ~2 = 6.437, p = 0.011 and p<0.05), whereas no significant difference in m.l555A>G mutation spectrum or prevalence of mitochondrial DNA12SrRNA was found between Uighur and Hui or Hui and Han. In the 126m.l555A>G mutation carriers, 52 cases were found to have a clear history of using aminoglycoside antibiotics. Results suggested that the application of aminoglycoside antibiotics in this region is an important reason for higher incidence of m.l555A>G mutation in the deaf-mute population.
机译:中国西北部的古老丝绸之路(也称为“西北丝绸之路”)从西安开始,经过甘肃,新疆,中亚,西亚以及连接地中海国家的陆地通道。本研究的目的是确定代表陕西,甘肃,青海,宁夏和新疆沿线普通人群的共2417例非综合征聋哑患者的线粒体DNA12SrRNA m.l555A> G突变频率。丝绸之路。应用酶消化和直接测序来鉴定序列变异。在研究人群中,线粒体DNA12S rRNA m.l555A> G突变的载带频率估计为5.21%(126/2417)。具体而言,维吾尔族和回族的载波频率分别为1.62%(3/185)和3.29%(10/304),而汉族为6.09%(113/1856)。维吾尔族和汉族之间存在统计学差异(卡方检验,χ〜2 = 6.437,p = 0.011和p <0.05),而在m.l555A> G突变谱或线粒体DNA12SrRNA的患病率中无显着差异。维吾尔族和回族或回族和汉族之间。在126m.l555A> G突变携带者中,发现52例有使用氨基糖苷类抗生素的明确病史。结果提示,在该地区应用氨基糖苷类抗生素是聋哑人群中m.l555A> G突变发生率较高的重要原因。

著录项

  • 来源
    《Genetic testing and molecular biomarkers》 |2010年第4期|P.527-531|共5页
  • 作者单位

    Ministry of Health of Gansu Province, Lanzhou, China Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Lanzhou University, Lanzhou, China;

    Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Lanzhou University, Lanzhou, China;

    Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Lanzhou University, Lanzhou, China;

    Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Lanzhou University, Lanzhou, China;

    Department of Otolaryngology-Head and Neck Surgery, The Second Hospital of Lanzhou University, Lanzhou, China;

    Department of Otolaryngology-Head and Neck Surgery, Chinese People's Liberation Army Institute of Otolaryngology, Chinese People's Liberation Army General Hospital, Beijing, China;

    Department of Otolaryngology-Head and Neck Surgery, Chinese People's Liberation Army Institute of Otolaryngology, Chinese People's Liberation Army General Hospital, Beijing, China;

    Department of Otolaryngology-Head and Neck Surgery, Chinese People's Liberation Army Institute of Otolaryngology, Chinese People's Liberation Army General Hospital, Beijing, China;

    Department of Otolaryngology-Head and Neck Surgery, Chinese People's Liberation Army Institute of Otolaryngology, Chinese People's Liberation Army General Hospital, Beijing, China;

    Department of Otolaryngology-Head and Neck Surgery Chinese People's Liberation Army Institute of Otolaryngology Chinese People's Liberation Army General Hospital 28 Fuxing Road Beijing 100853 China;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号